Enermiq Oy

The project addresses a valid and timely problem (recovery from Long COVID and overtraining) using a biochemical and data-driven approach. However, the submission contains severe discrepancies between claimed traction ('most people have used my product') and verifiable reality. External data indicates Enermiq Oy is a micro-scale entity (1 employee, ~€2k revenue in 2024) rather than a mass-market solution. The 'all time marketcap: 500000' figure in the revenue field is unclear and likely a valuation estimate rather than realized income. While the methodology shows promise as a boutique research/consultancy service, the project lacks the scale, team size, and adoption to support the broad claims made in the submission.